Ketogenic Diet-Based Therapy for Fatigue in Patients with Multiple Sclerosis
Nutrients · 08.05.2026 · 18 (10) · 1496
DOI: 10.3390/nu18101496 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Nutrients, online erschienen am 08.05.2026. Verfasst von Francesca Filippi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine (DMED), University of Udine, Via Colugna 50, 33100 Udine, Italy. Hauptthemen laut MEDLINE: Diet, Ketogenic, Multiple Sclerosis, Fatigue. Die Arbeit nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Fatigue is a frequent, disabling and difficult-to-treat symptom of multiple sclerosis (MS). Low-grade inflammation and energetic dysfunction have been proposed as mechanisms underlying the pathogenesis of this symptom. Owing to its anti-inflammatory and metabolic properties, there is a rationale for ketogenic diet (KD) application in this setting. The aim of this study was to evaluate the effects of KD on fatigue and other frequently associated symptoms in a carefully selected group of patients with MS.
Methods
We conducted a single-arm open-label interventional study on a strictly selected group of 16 non-obese patients with multiple sclerosis who were prescribed KD for three months. Fatigue, sleep quality, daytime somnolence, mood, and quality of life were assessed at baseline (T0), 1 month (T1), and 3 months (T3) using validated scales.
Results
With respect to baseline, at 3 months we observed a significant reduction in Fatigue Severity Scale (5.18 ± 1.02 vs. 4.16 ± 0.98; p = 0.042), Epworth Sleepiness Scale (8.46 ± 3.05 vs. 5.64 ± 2.46; p < 0.001), Pittsburgh Sleep Quality Index (5.64 ± 3.53 vs. 7.62 ± 2.59; p = 0.009), Depression Anxiety Stress Scales-21 depression (3.18 ± 2.93 vs. 6.15 ± 3.81; p = 0.036) and anxiety (5.15 ± 4.10 vs. 1.55 ± 1.92; p = 0.019) sub-scales, and an improvement in energy sub-scale of multiple sclerosis Quality of Life-54 (52.49 ± 12.83 vs. 37.43 ± 14.26; p = 0.042).
Conclusions
These findings suggest that KD might be useful for the treatment of fatigue, and they raise interest in the use of KD in the treatment of other symptoms frequently encountered in multiple sclerosis. Larger randomized controlled studies are needed to confirm these preliminary results.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine (DMED), University of Udine, Via Colugna 50, 33100 Udine, Italy.
- Clinical Neurology Unit, Udine University Hospital, Piazzale Santa Maria della Misericordia, 33100 Udine, Italy.
- Neurology Unit, Head Neck and Neuroscience Department, Santa Maria della Misericordia University Hospital, 33100 Udine, Italy.
- SC Neurology of Gorizia Monfalcone, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), 34100 Gorizia, Italy.
ORCID-Profile: Francesca Filippi, Riccardo Garbo, Ilaria Del Negro, Annacarmen Nilo, Sara Pez, Gian Luigi Gigli
Zitieren
APA
Filippi, F., Lorenzut, S., Garbo, R., Lamon, E., Del Negro, I., Nilo, A., Pez, S., Gigli, G. L., & Valente, M. (2026). Ketogenic Diet-Based Therapy for Fatigue in Patients with Multiple Sclerosis. Nutrients, 18(10), 1496. https://doi.org/10.3390/nu18101496
Vancouver
Filippi F, Lorenzut S, Garbo R, Lamon E, Del Negro I, Nilo A, et al. Ketogenic Diet-Based Therapy for Fatigue in Patients with Multiple Sclerosis. Nutrients. 2026;18(10):1496. doi:10.3390/nu18101496
BibTeX
@article{Filippi2026,
author = {Filippi, Francesca and Lorenzut, Simone and Garbo, Riccardo and Lamon, Eleonora and Del Negro, Ilaria and Nilo, Annacarmen and Pez, Sara and Gigli, Gian Luigi and Valente, Mariarosaria},
title = {Ketogenic Diet-Based Therapy for Fatigue in Patients with Multiple Sclerosis},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {10},
pages = {1496},
doi = {10.3390/nu18101496}
}
EUVIMED